I agree. I mean sure it was a bummer that Ms Mars couldn’t make it in person but she will MAKE THEMSELVES KNOWN to those investors. I love her determination and tanacity.
Institutional buying is nothing more than speculation at this point, this company has done over $15M in revs the last 2 years, why weren't institutions buying 2 years ago? Not bashing but people on this board keep saying that, what happens if institution's don't buy in? Will it make RXMD a lesser company? People shouldn't be betting on that IMO
News 
Market Data 
Discover 
